What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
Jack Cuzick mostly deals with Internal medicine, Gynecology, Breast cancer, Oncology and Tamoxifen.
His study looks at the relationship between Internal medicine and fields such as Gastroenterology, as well as how they intersect with chemical problems.
His Gynecology study incorporates themes from Cervical screening, Cervical intraepithelial neoplasia, Cervical cancer, Mass screening and Obstetrics.
Jack Cuzick has researched Breast cancer in several fields, including Odds ratio, Clinical trial, Surgery, Placebo and Risk factor.
His Oncology research is multidisciplinary, relying on both Chemotherapy, Adjuvant therapy, Proportional hazards model, Selective estrogen receptor modulator and Endometrial cancer.
His work carried out in the field of Tamoxifen brings together such families of science as Oncotype DX and Progesterone receptor.
His most cited work include:
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer (2099 citations)
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. (1701 citations)
- A wilcoxon-type test for trend (1371 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Breast cancer, Oncology, Gynecology and Tamoxifen.
His Internal medicine study is mostly concerned with Cancer, Anastrozole, Prostate cancer, Clinical trial and Hazard ratio.
His Breast cancer study integrates concerns from other disciplines, such as Odds ratio, Placebo, Randomized controlled trial and Risk factor.
The concepts of his Oncology study are interwoven with issues in Proportional hazards model, Estrogen receptor, Chemotherapy and Cohort.
His study in Gynecology is interdisciplinary in nature, drawing from both Cervical cancer, Cervical intraepithelial neoplasia, Colposcopy, Cytology and Obstetrics.
The various areas that Jack Cuzick examines in his Tamoxifen study include Aromatase and Adjuvant therapy.
He most often published in these fields:
- Internal medicine (53.65%)
- Breast cancer (41.20%)
- Oncology (40.36%)
What were the highlights of his more recent work (between 2016-2021)?
- Breast cancer (41.20%)
- Internal medicine (53.65%)
- Oncology (40.36%)
In recent papers he was focusing on the following fields of study:
His main research concerns Breast cancer, Internal medicine, Oncology, Cancer and Tamoxifen.
His Breast cancer research incorporates elements of Proportional hazards model, Cohort and Obstetrics.
He regularly links together related areas like MEDLINE in his Internal medicine studies.
His Oncology research incorporates themes from Framingham Risk Score, Chemotherapy, Recurrence score, Estrogen receptor and Stage.
Jack Cuzick combines subjects such as Lower risk and Intensive care medicine with his study of Cancer.
His work is dedicated to discovering how Tamoxifen, Gynecology are connected with Cytology and Mass screening and other disciplines.
Between 2016 and 2021, his most popular works were:
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. (494 citations)
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials (293 citations)
- Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial (154 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Disease
His primary areas of investigation include Breast cancer, Internal medicine, Oncology, Gynecology and Obstetrics.
His research integrates issues of Odds ratio and Case-control study in his study of Breast cancer.
His biological study spans a wide range of topics, including Interquartile range, Chemotherapy, Predictive value of tests, Meta-analysis and Proportional hazards model.
His Gynecology study incorporates themes from Cervical screening, Colposcopy, Vaccination and Mass screening.
The concepts of his Obstetrics study are interwoven with issues in Breast imaging, Cervical intraepithelial neoplasia, Disease and Human papillomavirus.
The Anastrozole study combines topics in areas such as Randomized controlled trial and Oncotype DX Breast Cancer Assay.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
